Primary resistance to anti-tuberculosis drugs in Addis Ababa

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 1, 1997, Pages 64-67

  Demissie, M ^a,d   Gebeyehu, M ^b   Berhane, Y ^c  

^a FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^b ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d NONE   (Ethiopia)

Author keywords

Drug resistance; Ethiopia; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ARTICLE; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; DRUG COMBINATION; DRUG EFFECT; ETHIOPIA; HUMAN; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ETHAMBUTOL; ETHIOPIA; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MULTICENTER STUDIES; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0031061589     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Porter J D H, McAdam K P W J. Tuberculosis in Africa in the AIDS era: the role of chemoprophylaxis. Trans R Soc Trop Med Hyg 1992; 86: 467-469.
2. Styblo K. Tuberculosis control and surveillance. In: Flenley D C, Petty T L eds. Recent advances in respiratory medicine. Edinburgh, Churchill Livingstone. 1986; 77-108.
3. Azbite M. Tuberculin survey in Ethiopia. Kekkaku 1991; 67: 8539-8544.
4. Jacobs R F. Multiple drug resistant tuberculosis. Clin Infect Dis 1994; 19: 1-10.
5. Unpublished report the Ministry of Health, Department of Epidemiology and AIDS, 1994.
6. Weyer K, Kleeberg H H. Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa. Tubercle Lung Dis 1992; 73: 106-112.
7. Iseman M D. Treatment of multi-drug resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
8. Jarallah J S, Elias A K, Al Hajjaj M S, Bukhari M S, Al Shareef A H M, Al-Shamman S A. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle Lung Dis 1992; 73: 113-115.
9. Kim S J, Hong Y P. Drug resistance of Mycobacterium tuberculosis in Korea. Tubercle Lung Dis 1992; 73: 219-224.
10. Nunn P, Felten M. Surveillance of resistance to anti-tuberculosis drugs in developing countries. Tubercle Lung Dis 1994; 75: 163-167.
11. Dias E, Ghebre Michael S, Hoffner S E, Martins L, Norberg R, Källenius G. Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tubercle Lung Dis 1993; 74: 129-130.
12. Valenzuela M T, Garcia P, Ponce J, Lepe R, Velasco M, Piffardi S. Drug resistance of M. tuberculosis in Chile. Bull Int Union Tuberc Lung Dis 1989; 64 (2): 13-14.
13. Laszlo A, De Kantor I N. Random sample survey of initial drug resistance among tuberculosis cases in South America. Bull Wld Health Organ 1994; 72 (4): 603-610.
14. Rodrigues L C, Smith P G. Tuberculosis in developing countries and methods for its control. Trans Roy Soc Trop Med Hyg 1990; 84: 739-744.
15. Wolde K, Lemma E. Primary resistance to the major anti-tuberculosis drugs in Ethiopia. Ethiop Med J 1986; 24: 15-18.
16. Lemma E, Valdivia Alvarez J A, Gebre-Tsadik G, Echemendia Font M. Drug sensitivity pattern of Mycobacterium tuberculosis isolated in Addis Ababa. Ethiop Med J 1984; 22: 93-96.
17. Crofton J, Horne N, Miller F. Clinical Tuberculosis, MacMillan, London 1992, 94-96.
18. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/94.
19. Demissie M. Defaulting from tuberculosis treatment in Addis Ababa Tuberculosis Centre and factors associated with it. Ethiop Med J 1994; 32: 97-106.